Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pear Therapeutics

Explore full profile

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need

Boston, United StatesFounded 2013Biotech & Life Sciences
Valuation $690K Market cap · 2026
Revenue $13M Latest reported FY

At a glance

Founded
2013
Headquarters
Boston, United States
Listing
Public via SPAC 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning Pear Therapeutics.

See all news

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • JAZZ Venture Partners
  • Bridge Builders Collaborative
  • Arboretum Ventures
  • Novartis
  • 5AM Ventures

Series B and later12 investors entered at this stage

  • University of Virginia
  • Temasek
  • Shanda Group
  • QUAD Investment Management
  • Pilot House Ventures
  • EDBI
  • Dartmouth College
  • Karolinska Institute
  • SoftBank
  • SoftBank Vision Fund
  • Trustbridge Partners
  • University of Southern California
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
410 monthly visits
across markets
🇪🇬 Egypt97.6%
Top 1 markets shown

Patents

Estimated portfolio value
$10M

8 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pear Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pear Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.